Piribedil
Piribedil is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target alpha-1A adrenergic receptor, alpha-2A adrenergic receptor, 5-hydroxytryptamine receptor 2B, D(3) dopamine receptor, D(4) dopamine receptor, alpha-2C adrenergic receptor, D(2) dopamine receptor, and 5-hydroxytryptamine receptor 1A.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
nervous system diseases | D009422 |
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
parkinson disease | EFO_0002508 | D010300 | G20 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
5 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Parkinson disease | D010300 | EFO_0002508 | G20 | — | — | 1 | — | 3 | 4 |
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Tinnitus | D014012 | HP_0000360 | H93.1 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | PIRIBEDIL |
INN | piribedil |
Description | 2-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]pyrimidine is a N-arylpiperazine. |
Classification | Small molecule |
Drug class | vasodilators (undefined group) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | c1cnc(N2CCN(Cc3ccc4c(c3)OCO4)CC2)nc1 |
Identifiers
PDB | — |
CAS-ID | 3605-01-4 |
RxCUI | 8353 |
ChEMBL ID | CHEMBL1371770 |
ChEBI ID | — |
PubChem CID | 4850 |
DrugBank | DB12478 |
UNII ID | DO22K1PRDJ (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
ADRA1A
ADRA1A
ADRA2A
ADRA2A
HTR2B
HTR2B
DRD3
DRD3
DRD4
DRD4
ADRA2C
ADRA2C
DRD2
DRD2
HTR1A
HTR1A
Organism
Homo sapiens
Gene name
ADRA1A
Gene synonyms
ADRA1C
NCBI Gene ID
Protein name
alpha-1A adrenergic receptor
Protein synonyms
Alpha-1A adrenoceptor, Alpha-1A adrenoreceptor, Alpha-1C adrenergic receptor, Alpha-adrenergic receptor 1c, G protein coupled receptor
Uniprot ID
Mouse ortholog
Adra1a (11549)
alpha-1A adrenergic receptor (Q8BV77)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 673 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
151 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more